Clinical trial

HALT Progression of Polycystic Kidney Disease Study A

NCT00283686

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE3

Study timeline

Study start (actual)2006-01-01Date precision: month

Registry last updated2020-04-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Kidney, Polycysticunresolved

Interventions

LisinoprilDRUG · verified · RxNorm: lisinopril

TelmisartanDRUG · verified · RxNorm: telmisartan

Standard Blood Pressure ControlOTHER

Low Blood Pressure ControlOTHER

Sponsors & collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)lead sponsor

Boehringer Ingelheimcollaborator

Merck Sharp & Dohme LLCcollaborator

Polycystic Kidney Disease Foundationcollaborator

University of Pittsburghcollaborator

Washington University School of Medicinecollaborator

Mapped research locations

BostonMassachusetts, United States2 AtlantaGeorgia, United States1 ClevelandOhio, United States1 AuroraColorado, United States1 RochesterMinnesota, United States1 Kansas CityKansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00283686 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.